Over 15 years of experience in clinical trials
Tamro can handle all types of investigational medicinal products. The quality and regulatory compliance of clinical studies is verified throughout the process.
Tamro imports the IMPs on behalf of the sponsor of the clinical trial, and secures importing authorisations for special products.Tamro’s IMP handling and warehousing facilities meet strict quality and authority requirements. Tamro handles and stores products requiring cold storage as well as narcotics, cytostatic agents and other IMPs that require special handling. Tamro distributes IMPs to hospital pharmacies and research centres in Finland according to Good Distribution Practice (GDP).
IMP returns are collected from research centres and moved to the segregated warehouse facilities to wait for disposal or exporting. After receiving a written disposal permit, Tamro disposes IMPs according to local regulations.
Tamro also provides archiving services for documentation for the duration required by legislation.
Tamro’s clinical trial supply services include the following
• Relabelling under Tamro's GMP license
• Software application for IMP monitoring
Quality management system procedures are strictly adhered to in the handling of IMPs
All IMPs stored by Tamro are traceable at package level. The electronic system used allows flexible reporting and provides the customers continuous visibility into the process.
Tamro’s GMP license granted by the Finnish Medicines Agency, Fimea, allows Tamro to relabel and repackage IMPs. Procedures for batch release are specified in a separate quality agreement.
All members of the team are qualified pharmaceutical or health care professionals with extensive experience in handling investigational medicinal products.